CN103006873B - 治疗呼吸系统疾病的中药组合物的纳米制剂的制备方法 - Google Patents
治疗呼吸系统疾病的中药组合物的纳米制剂的制备方法 Download PDFInfo
- Publication number
- CN103006873B CN103006873B CN201310007471.0A CN201310007471A CN103006873B CN 103006873 B CN103006873 B CN 103006873B CN 201310007471 A CN201310007471 A CN 201310007471A CN 103006873 B CN103006873 B CN 103006873B
- Authority
- CN
- China
- Prior art keywords
- extraction
- parts
- pressure
- chinese herbal
- crude drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000023504 respiratory system disease Diseases 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 115
- 229940079593 drug Drugs 0.000 claims abstract description 61
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 17
- 238000007873 sieving Methods 0.000 claims abstract description 11
- 238000000605 extraction Methods 0.000 claims description 71
- 239000000341 volatile oil Substances 0.000 claims description 50
- 239000002904 solvent Substances 0.000 claims description 42
- 239000000203 mixture Substances 0.000 claims description 32
- 238000002425 crystallisation Methods 0.000 claims description 31
- 230000008025 crystallization Effects 0.000 claims description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 27
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 27
- 238000009472 formulation Methods 0.000 claims description 15
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 12
- 238000012545 processing Methods 0.000 claims description 11
- 238000010298 pulverizing process Methods 0.000 claims description 11
- 239000007921 spray Substances 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 238000013270 controlled release Methods 0.000 abstract description 2
- 210000002345 respiratory system Anatomy 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000001405 Artemisia annua Nutrition 0.000 abstract 1
- 240000000011 Artemisia annua Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000245214 Mentha canadensis Species 0.000 abstract 1
- 235000001878 Mentha haplocalyx Nutrition 0.000 abstract 1
- 241000681946 Rhododendron dauricum Species 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 20
- 210000004072 lung Anatomy 0.000 description 7
- 230000000391 smoking effect Effects 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000009388 chemical precipitation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 238000012695 Interfacial polymerization Methods 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 241000244155 Taenia Species 0.000 description 1
- 240000000377 Tussilago farfara Species 0.000 description 1
- 235000004869 Tussilago farfara Nutrition 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004807 desolvation Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 238000007709 nanocrystallization Methods 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310007471.0A CN103006873B (zh) | 2013-01-09 | 2013-01-09 | 治疗呼吸系统疾病的中药组合物的纳米制剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310007471.0A CN103006873B (zh) | 2013-01-09 | 2013-01-09 | 治疗呼吸系统疾病的中药组合物的纳米制剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103006873A CN103006873A (zh) | 2013-04-03 |
CN103006873B true CN103006873B (zh) | 2014-04-02 |
Family
ID=47956336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310007471.0A Active CN103006873B (zh) | 2013-01-09 | 2013-01-09 | 治疗呼吸系统疾病的中药组合物的纳米制剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103006873B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109078046B (zh) * | 2018-10-12 | 2021-06-25 | 广州医科大学 | 一种超临界co2萃取镇眩汤中挥发油的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101780237B (zh) * | 2010-04-20 | 2011-04-13 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗咳嗽的中药组合物及其制备方法 |
CN102349991A (zh) * | 2011-05-29 | 2012-02-15 | 王红芳 | 一种杀病毒防流感的组合物及该组合物所制成的防感冒贴 |
-
2013
- 2013-01-09 CN CN201310007471.0A patent/CN103006873B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103006873A (zh) | 2013-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432374A (zh) | 一种治疗猪肺炎的药物 | |
CN101164611A (zh) | 治疗寒邪束肺型百日咳的中药 | |
CN104888070A (zh) | 一种治疗呼吸内科肺结核的药物配方及制作方法 | |
CN103006873B (zh) | 治疗呼吸系统疾病的中药组合物的纳米制剂的制备方法 | |
CN103961614A (zh) | 用于治疗呼吸系统疾病的中药组合物及其制备方法和用途 | |
CN105125637A (zh) | 一种花类中药材免煎剂的制备方法及其应用 | |
CN104435567A (zh) | 一种含绞股蓝的治疗痛风的中药组合物 | |
CN104435079A (zh) | 一种治疗痛风的中药组合物 | |
CN106310027A (zh) | 一种复方石斛清肺制剂及其制备方法和应用 | |
CN104491483A (zh) | 一种改善过敏性疾病的中药组合物、其制备方法及应用 | |
CN109718360A (zh) | 一种治疗哮喘所致黏痰的散剂 | |
CN104042885A (zh) | 新小儿肺热咳喘口服制剂 | |
CN103736051A (zh) | 一种血管瘤护理药物及其制作方法 | |
CN103990091A (zh) | 一种用于治疗感冒发热的药物组合物及其制备方法 | |
CN103893536A (zh) | 一种防治因雾霾诱发咽炎的组合物及泡腾片 | |
CN107029098A (zh) | 一种中药制剂咳喘停胶囊 | |
CN102085313A (zh) | 一种具有止咳作用的组合物 | |
CN107714839B (zh) | 一种治疗慢性鼻炎的中药组合物及其制备方法 | |
CN101007147A (zh) | 一种治疗胃肠疾病的中药组合物分散片及其制备方法 | |
CN106177689A (zh) | 一种具有清肺化痰止嗽作用的组合物及其制备方法 | |
CN105288285A (zh) | 一种用于治疗慢性支气管炎的药物制剂 | |
CN105106663A (zh) | 一种用于治疗心律失常的药物制剂 | |
CN105535895B (zh) | 一种治疗痰咳的中药组合物 | |
CN105056140A (zh) | 一种治疗荨麻疹及湿疹的中药组合物 | |
CN104398564A (zh) | 一种含有雷公藤的治疗痛风的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN FEELLIFE BIOSCIENCE CO., LTD. Free format text: FORMER OWNER: HUA JIAN Effective date: 20140704 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140704 Address after: 518000, Guangdong, Baoan District, Xixiang street, Huang Tian Yang Industrial Zone phase first, third, fourth, 5 and 7 (first buildings, 2 buildings, B District, fifth buildings, 5 floor, B District), Shenzhen Patentee after: Feellife Bioscience International Co., Ltd. Address before: 518000 Guangdong city of Shenzhen province Nanshan District high tech Industrial Park, science and technology twelve South Road, Fangda building 12A Patentee before: Hua Jian |
|
CP03 | Change of name, title or address |
Address after: 518000, Shenzhen, Guangdong, Baoan District province Xixiang Street Huang Yang Yang Industrial Zone, the first building, 2 floor Patentee after: Shenzhen Vatican living life science Limited by Share Ltd Address before: 518000, Guangdong, Baoan District, Xixiang street, Huang Tian Yang Industrial Zone phase first, third, fourth, 5 and 7 (first buildings, 2 buildings, B District, fifth buildings, 5 floor, B District), Shenzhen Patentee before: Feellife Bioscience International Co., Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180814 Address after: 518000, 2 floor, phase 1, Yang Bei Industrial Zone, Baoan District, Xixiang, Shenzhen, Guangdong. Co-patentee after: Lv Quanfu Patentee after: Shenzhen Vatican living life science Limited by Share Ltd Address before: 518000, 2 floor, phase 1, Yang Bei Industrial Zone, Baoan District, Xixiang, Shenzhen, Guangdong. Patentee before: Shenzhen Vatican living life science Limited by Share Ltd |
|
TR01 | Transfer of patent right |